Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Jan-31-23 | Jan-31-22 | Jan-31-21 | Jan-31-20 |
| 10-K | 10-K | 10-K | 10-K |
Revenues | 1,058.6 | 892.3 | 607.6 | 336.2 |
Revenue growth | 18.6% | 46.8% | 80.8% | |
Cost of goods sold | 180.1 | 168.9 | 65.9 | 59.4 |
Gross profit | 878.5 | 723.4 | 541.8 | 276.8 |
Gross margin | 83.0% | 81.1% | 89.2% | 82.3% |
Selling, general and administrative [+] | 941.1 | 947.7 | 542.2 | 663.0 |
Sales and marketing | 701.6 | 697.7 | 380.2 | 483.3 |
General and administrative | 239.5 | 250.0 | 162.0 | 179.6 |
Research and development | 285.8 | 276.7 | 109.9 | 131.1 |
EBITDA [+] | -329.6 | -486.2 | -98.0 | -508.6 |
EBITDA growth | -32.2% | 396.2% | -80.7% | |
EBITDA margin | -31.1% | -54.5% | -16.1% | -151.3% |
Depreciation | 11.8 | 9.6 | 9.7 | 8.0 |
EBITA | -341.4 | -495.8 | -107.7 | -516.6 |
EBITA margin | -32.2% | -55.6% | -17.7% | -153.7% |
Amortization of intangibles | 6.9 | 5.1 | 2.6 | 0.7 |
EBIT [+] | -348.3 | -500.9 | -110.3 | -517.3 |
EBIT growth | -30.5% | 354.1% | -78.7% | |
EBIT margin | -32.9% | -56.1% | -18.2% | -153.9% |
Interest income | 28.0 | 3.6 | 1.2 | 6.7 |
Interest income | 28.0 | 3.6 | 1.2 | 6.7 |
Other income (expense), net [+] | 2.8 | -13.5 | 14.5 | -6.6 |
Other | 2.8 | -13.5 | 14.5 | -6.6 |
Pre-tax income | -317.6 | -510.9 | -94.7 | -517.1 |
Income taxes | 10.8 | 14.7 | -2.3 | 2.8 |
Tax rate | | | 2.4% | |
Net income | -328.4 | -525.6 | -92.4 | -519.9 |
Net margin | -31.0% | -58.9% | -15.2% | -154.7% |
|
Basic EPS [+] | ($0.60) | ($1.16) | ($0.55) | ($3.41) |
Growth | -48.2% | 110.5% | -83.9% | |
Diluted EPS [+] | ($0.60) | ($1.16) | ($0.55) | ($3.41) |
Growth | -48.2% | 110.5% | -83.9% | |
|
Shares outstanding (basic) [+] | 548.0 | 454.6 | 168.3 | 152.4 |
Growth | 20.5% | 170.2% | 10.4% | |
Shares outstanding (diluted) [+] | 548.0 | 454.6 | 168.3 | 152.4 |
Growth | 20.5% | 170.2% | 10.4% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|